<p>Cuprina Holdings (Cayman) Ltd. has entered into a joint venture agreement with Singapore-based Aiodine Laboratory to develop, test, and market Aiodine’s iodine-based disinfectant solution for use in treating chronic and acute wounds, as well as for applications such as disinfectants and home-use antiseptics. Additionally, Cuprina has signed a Memorandum of Understanding with Singapore Biowaste Solutions Pte Ltd (SBS) to explore integrating Cuprina’s medical waste recycling technology into SBS’s waste management facility in Singapore. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cuprina Holdings (Cayman) Ltd. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9599297-en) on December 09, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT)</p>

CUPR

<p>Cuprina Holdings has formed a joint venture with Aiodine Laboratory to develop iodine-based wound treatments. Additionally, Cuprina signed an MOU with Singapore Biowaste Solutions to explore integrating medical waste recycling technology into SBS's facility. This news was generated by AI and is for informational purposes only.</p>

Cuprina Holdings Forms Joint Venture With Aiodine Laboratory for Iodine-Based Wound Treatments